What's being said on the web about "qnexa"

  • I believe VVUS and their coming drug , Qnexa , are on the verge of being the next needed one-a- day blockbuster for weight loss. Before going any further, I encourage all interested readers to review the data themselves. ... [view original]

  • Qnexa (phentermine and topiramate) is a new drug in development for the treatment of obesity. Qnexa information includes news, clinical trial results and side effects. [view original]

  • Vivus Inc.'s (VVUS) experimental anti-obesity drug Qnexa was shown to reduce sleep apnea, when breathing stops briefly during sleep, by 69% in a mid-stage. [view original]

  • Qnexa Treatment Results in 69 Reduction in Sleep Apnea Events VIVUS, Inc. (NASDAQ VVUS) today announced positive results from a phase 2 study evaluating the saf. [view original]

  • Qnexa, an experimental weight-loss drug developed by Vivus, has showed that it can reduce sleep apnea, the company confirmed last Thursday. While the drug is. [view original]

  • Qnexa Treatment Results in 69% Reduction in Sleep Apnea Events. [view original]

  • Qnexa, an anti-obesity drug, which is being developed by Vivus Inc. showed success in reducing incidences of sleep b 69%. The company filed for regulatory. [view original]

  • VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication. The study announced today demonstrated statistically significant improvement ... [view original]

  • Three diet pills are about to be aprroved from the FDA, one is called Qnexa and may help millions with obesity problems... [view original]

  • Drug company Vivius Inc reported recently that the first of 3 trials they conducted found that overweight patients treated with their experimental drug Qnexa lost 9.3% of their body weight on average. ... [view original]

  • (Press Release)-A phase 2 study evaluating the safety and efficacy of the investigational drug Qnexa for the treatment of obstructive sleep apnea (OSA) showed. [view original]

  • VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics) [view original]

  • Vivus's better-than-expected Phase III data with obesity drug Qnexa started the goldmine versus graveyard debate once again. In one corner: the folk. [view original]

  • The Online Clinic brings you the latest information on Qnexa Moves Forward to FDA. [view original]

  • Shares of Vivus jumped in after-market trading after the developer unveiled new data that demonstrated its experimental obesity drug Qnexa significantly reduced sleep apnea in a mid-stage trial. Qnexa, which has attracted considerable ... [view original]

  • Highlights of the study include: -- Patients treated with Qnexa for 28 weeks had a 69% reduction in sleep apnea events -- Qnexa treatment reduced the number of apnea/hypopnea events from a mean of 46 events per hour of sleep to 14 ... [view original]

  • Shift Work Disorder News Qnexa can help reduce sleep apnea Shift Work Disorder News Qnexa, an experimental weight-loss drug developed by Vivus, has showed that it can reduce sleep apnea, the company confirmed last Thursday. [view original]

  • Qnexa™ is a proprietary therapeutic formulation and dosing regimen that incorporates the active ingredients from two previously approved products with demonstrated weight loss properties: phentermine and topiramate. ... [view original]

  • The three most advanced new weight loss drugs in clinical development are lorcaserin, Qnexa and Contrave. Each of the later products contains two active ingredients that are already available separately; Contrave consists of the ... [view original]

  • January 201, announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of ... [view original]

share

Social web results for: qnexa

digg.com Digg_fav

twitter Twitter_fav

Picture results for: qnexa

flickr Flickr_fav
  • Sorry, we couldn't find any relevant results.
photobucket Photobucket_fav
  • Sorry, we couldn't find any relevant results.

Blog results for: qnexa

blogsearch.google.com Blogsearch_fav

  • Qnexa Moves Forward to FDA The Online Clinic brings you the latest information on Qnexa Moves Forward to FDA.From:
  • Qnexa Qnexa™ is a proprietary therapeutic formulation and dosing regimen that incorporates the active ingredients from two previously approved products with demonstrated weight loss properties: phentermine and topiramate. ...From:
  • Sleep Apnea and Qnexa Qnexa is an anti-obesity drug manufactured by Vivus, Inc. A 28 week study was done on 45 obese sleep apnea patients in 69% of the participants sleep apnea was reduced due to weight loss and a greater concentration of oxygen. ...From:
  • Qnexa New Drug Application Qnexa (phentermine and topiramate) is a new drug in development for the treatment of obesity. Qnexa information includes news, clinical trial results and side effects.From:
  • Mid Stage Trial of Qnexa Shows Reduction in Apnea | TopNews Unite.. A small-scale, mid-stage trial of Qnexa, which is an experimental weight-loss medicine developed by Vivus Inc., has revealed that the drug can actually manage to reduce the incidence of sleep apnea events by about 69%, as confirmed by ...From:

bloglines.com Bloglines

twingly.com Twingly

  • Sorry, we couldn't find any relevant results.

News results for: qnexa

wikio news Wikio_fav

  • Five Drugs To Watch (Assuming FDA Approval) (Pharmalot) ... - a clotbuster from Bayer and Johnson & Johnson; Prolia * - an osteoporosis treatment from Amgen; Qnexa * - the Vivus obesity pill; Provenge * - Dendreon’s controversial prostate cancer vaccine. * - not yet approved by the FDASource : Pharmalot..Date:
  • Qnexa Moves Forward to FDA (Online Clinic News) ... in clinical trials but perhaps the most promising from a perspective of efficacy is a drug called Qnexa. In clinical trials Qnexa proved to be more effective than any weight loss drug that has ever gone before it (other than perhaps the disastrou..Date:
  • Investors betting heavily on Vivus obesity drug (Market Watch) Investors in biotech group Vivus Inc. are betting heavily that its new anti-obesity drug Qnexa could be a game-changer in the weight-loss market, but some analysts caution that its approval isn’t necessarily a slam-dunk.Source : Market Watch (subsc..Date:
  • Vivus posts more positive ED data (Fiercebiotech) ... the company revealed earlier this month that its highly anticipated experimental obesity drug Qnexa significantly reduced sleep apnea in a mid-stage trial. - see Vivus' release Related Articles: On a hot streak, Vivus posts positive ED data Vivus..Date:
  • Taser adds mobile phone monitoring tool to its arsenal (All 24 Ho.. ... Present at JP Morgan Healthcare Conference VIVUS Announces Positive Results From Phase 2 Study of Qnexa in Obstructive Sleep Apnea Depression Fought Better Without Antidepressants HP unveils new PCs Kodak Brings the Consumer Electronics Show to Y..Date:

yahoo news YahooNews_fav

Product results for: qnexa

ebay Ebay_fav
  • Sorry, we couldn't find any relevant results.
amazon Amazon_fav
  • Sorry, we couldn't find any relevant results.